Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Phalloplasty outcomes under review: what patients really think

NCT ID NCT04314141

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This completed study from a French hospital center surveyed 143 patients who had phalloplasty surgery between 2007 and 2018. Researchers collected data on surgical results, sexual quality of life, and patient satisfaction using questionnaires and medical records. The goal is to better understand outcomes and improve both surgical techniques and pre-surgery information for future patients.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could help surgeons improve phalloplasty techniques and provide better information to future patients about what to expect.
What could go wrong
This is an observational study, not a treatment trial, so it won't directly change patient care. Results depend on patient recall and may not apply to all surgical methods.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

143 people

The number who actually took part.

Started

May 2020

Finished

Nov 2020

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients who have undergone a phalloplasty surgery in the University Lyon Sud Hospital or Croix Rousse Hospital, between 1 January 2007 and 31 October 2018, with at least one year of back on their surgery procedures. Patients concerned with this surgery are : * transgender patients whose reassignment surgery was validated by a minimum of three members of GRETTIS, including a psychiatrist. * Patients cis males with congenital malformations, or having suffered a total or partial amputation of verge

Ages

20 to 73 years

Sex

Male participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Major patients * Patients who have undergone a phalloplasty surgery in the University Lyon Sud Hospital or Croix Rousse Hospital, between 1 January 2007 and 31 October 2018 * Patients with at least one year of back on their surgery procedures * Transgender patients whose reassignment surgery was validated by a minimum of three members of GRETTIS (Groupe de Recherche, d'Etude et de Traitement des Troubles de l'Identité Sexuelle), including a psychiatrist Or Patients cis males with congenital malformations, or having suffered a total or partial amputation of verge * Patients who do not oppose orally to participate in the study, after information * Patients who have given their consent for the audio recording for patients taking part in semi - directive interviews Exclusion Criteria: * Minor patients or patients under legal protection * Refusal to participate in the study * No understanding of the French language

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Phalloplasty are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Urology Department, Hospices Civis de Lyon

    Pierre-Bénite, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.